| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hormone binding | 5.39e-04 | 103 | 31 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 5.78e-04 | 23 | 31 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 7.41e-04 | 26 | 31 | 2 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 7.41e-04 | 26 | 31 | 2 | GO:0004950 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 1.42e-03 | 36 | 31 | 2 | GO:0140416 | |
| GeneOntologyCellularComponent | pseudopodium | 3.64e-04 | 18 | 33 | 2 | GO:0031143 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 4.06e-04 | 19 | 33 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 7.67e-04 | 26 | 33 | 2 | GO:0099571 | |
| Domain | Cul7 | 9.07e-06 | 3 | 33 | 2 | PF11515 | |
| Domain | CPH_domain | 9.07e-06 | 3 | 33 | 2 | IPR021097 | |
| Domain | Galactose-bd-like | 2.20e-05 | 94 | 33 | 4 | IPR008979 | |
| Domain | EF-hand_Ca_insen | 4.52e-05 | 6 | 33 | 2 | IPR014837 | |
| Domain | EFhand_Ca_insen | 4.52e-05 | 6 | 33 | 2 | PF08726 | |
| Domain | APC_su10/DOC_dom | 6.32e-05 | 7 | 33 | 2 | IPR004939 | |
| Domain | APC10 | 6.32e-05 | 7 | 33 | 2 | SM01337 | |
| Domain | DOC | 6.32e-05 | 7 | 33 | 2 | PS51284 | |
| Domain | ANAPC10 | 6.32e-05 | 7 | 33 | 2 | PF03256 | |
| Domain | Cullin_Nedd8 | 8.42e-05 | 8 | 33 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 8.42e-05 | 8 | 33 | 2 | SM00884 | |
| Domain | Cullin_neddylation_domain | 8.42e-05 | 8 | 33 | 2 | IPR019559 | |
| Domain | Cullin_homology | 1.08e-04 | 9 | 33 | 2 | IPR016158 | |
| Domain | Cullin_N | 1.35e-04 | 10 | 33 | 2 | IPR001373 | |
| Domain | Cullin | 1.35e-04 | 10 | 33 | 2 | PF00888 | |
| Domain | CULLIN_2 | 1.35e-04 | 10 | 33 | 2 | PS50069 | |
| Domain | CULLIN_1 | 1.35e-04 | 10 | 33 | 2 | PS01256 | |
| Domain | - | 2.87e-04 | 73 | 33 | 3 | 2.60.120.260 | |
| Domain | Rib_L2_dom2 | 4.55e-04 | 18 | 33 | 2 | IPR014722 | |
| Domain | - | 4.55e-04 | 18 | 33 | 2 | 2.30.30.30 | |
| Domain | FA58C | 6.23e-04 | 21 | 33 | 2 | SM00231 | |
| Domain | FA58C_3 | 6.23e-04 | 21 | 33 | 2 | PS50022 | |
| Domain | FA58C_1 | 6.23e-04 | 21 | 33 | 2 | PS01285 | |
| Domain | FA58C_2 | 6.23e-04 | 21 | 33 | 2 | PS01286 | |
| Domain | Actinin_actin-bd_CS | 7.48e-04 | 23 | 33 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 7.48e-04 | 23 | 33 | 2 | PS00020 | |
| Domain | ACTININ_1 | 7.48e-04 | 23 | 33 | 2 | PS00019 | |
| Domain | Spectrin | 7.48e-04 | 23 | 33 | 2 | PF00435 | |
| Domain | EGF | 7.51e-04 | 235 | 33 | 4 | SM00181 | |
| Domain | F5_F8_type_C | 8.15e-04 | 24 | 33 | 2 | PF00754 | |
| Domain | FA58C | 8.15e-04 | 24 | 33 | 2 | IPR000421 | |
| Domain | EGF-like_dom | 9.31e-04 | 249 | 33 | 4 | IPR000742 | |
| Domain | Spectrin_repeat | 1.19e-03 | 29 | 33 | 2 | IPR002017 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.45e-03 | 32 | 33 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.45e-03 | 32 | 33 | 2 | PS51406 | |
| Domain | Spectrin/alpha-actinin | 1.45e-03 | 32 | 33 | 2 | IPR018159 | |
| Domain | SPEC | 1.45e-03 | 32 | 33 | 2 | SM00150 | |
| Domain | FIBRINOGEN_C_1 | 1.45e-03 | 32 | 33 | 2 | PS00514 | |
| Domain | LAM_G_DOMAIN | 2.05e-03 | 38 | 33 | 2 | PS50025 | |
| Domain | Laminin_G_2 | 2.26e-03 | 40 | 33 | 2 | PF02210 | |
| Domain | LDLR_class-A_CS | 2.26e-03 | 40 | 33 | 2 | IPR023415 | |
| Domain | LamG | 2.73e-03 | 44 | 33 | 2 | SM00282 | |
| Domain | Ldl_recept_a | 2.86e-03 | 45 | 33 | 2 | PF00057 | |
| Domain | - | 2.98e-03 | 46 | 33 | 2 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.25e-03 | 48 | 33 | 2 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.38e-03 | 49 | 33 | 2 | IPR002172 | |
| Domain | LDLa | 3.38e-03 | 49 | 33 | 2 | SM00192 | |
| Domain | LDLRA_2 | 3.38e-03 | 49 | 33 | 2 | PS50068 | |
| Domain | Laminin_G | 4.70e-03 | 58 | 33 | 2 | IPR001791 | |
| Domain | CH | 5.87e-03 | 65 | 33 | 2 | SM00033 | |
| Domain | CH | 6.78e-03 | 70 | 33 | 2 | PF00307 | |
| Domain | - | 6.95e-03 | 222 | 33 | 3 | 1.25.10.10 | |
| Domain | - | 6.97e-03 | 71 | 33 | 2 | 1.10.418.10 | |
| Domain | CH | 7.36e-03 | 73 | 33 | 2 | PS50021 | |
| Domain | CH-domain | 7.75e-03 | 75 | 33 | 2 | IPR001715 | |
| Domain | EGF_3 | 8.12e-03 | 235 | 33 | 3 | PS50026 | |
| Domain | EGF_1 | 1.01e-02 | 255 | 33 | 3 | PS00022 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 5.75e-07 | 171 | 33 | 5 | 20201926 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 31150793 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 26807827 | ||
| Pubmed | Colocalization of α-actinin and synaptopodin in the pyramidal cell axon initial segment. | 2.62e-06 | 3 | 33 | 2 | 21940706 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 16875676 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17229476 | ||
| Pubmed | Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. | 2.62e-06 | 3 | 33 | 2 | 15964813 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 17298945 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 8104223 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 10656685 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 16807302 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 1629252 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 16510730 | ||
| Pubmed | The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. | 8.72e-06 | 5 | 33 | 2 | 12837758 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 19943616 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 24793696 | ||
| Pubmed | Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. | 8.72e-06 | 5 | 33 | 2 | 15841212 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 17332328 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 18425115 | ||
| Pubmed | In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development. | 1.31e-05 | 6 | 33 | 2 | 34143959 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 22693585 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 11724819 | ||
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 2.44e-05 | 8 | 33 | 2 | 20215401 | |
| Pubmed | Mice deficient in alpha-actinin-4 have severe glomerular disease. | 2.44e-05 | 8 | 33 | 2 | 12782671 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 3.91e-05 | 10 | 33 | 2 | 20368620 | |
| Pubmed | Origin, fate and dynamics of macrophages at central nervous system interfaces. | 3.91e-05 | 10 | 33 | 2 | 27135602 | |
| Pubmed | Ubiquitin ligase TRIM71 suppresses ovarian tumorigenesis by degrading mutant p53. | 4.78e-05 | 11 | 33 | 2 | 31570706 | |
| Pubmed | Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. | 5.73e-05 | 12 | 33 | 2 | 15465019 | |
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 22653443 | ||
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 36706168 | ||
| Pubmed | 9.10e-05 | 15 | 33 | 2 | 11440986 | ||
| Pubmed | Genome-wide association study of chronic periodontitis in a general German population. | 1.05e-04 | 96 | 33 | 3 | 24024966 | |
| Pubmed | 1.18e-04 | 17 | 33 | 2 | 26389685 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 1.42e-04 | 861 | 33 | 6 | 36931259 | |
| Pubmed | Interactome mapping suggests new mechanistic details underlying Alzheimer's disease. | 1.61e-04 | 111 | 33 | 3 | 21163940 | |
| Pubmed | 1.81e-04 | 21 | 33 | 2 | 22842622 | ||
| Pubmed | FoxP1 orchestration of ASD-relevant signaling pathways in the striatum. | 1.99e-04 | 22 | 33 | 2 | 26494785 | |
| Pubmed | 2.38e-04 | 24 | 33 | 2 | 33705438 | ||
| Pubmed | 2.56e-04 | 130 | 33 | 3 | 12421765 | ||
| Pubmed | Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. | 3.02e-04 | 27 | 33 | 2 | 36899856 | |
| Pubmed | Specification of CNS macrophage subsets occurs postnatally in defined niches. | 3.02e-04 | 27 | 33 | 2 | 35444273 | |
| Pubmed | 3.25e-04 | 28 | 33 | 2 | 30947518 | ||
| Pubmed | Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. | 3.49e-04 | 29 | 33 | 2 | 31491374 | |
| Pubmed | 3.74e-04 | 30 | 33 | 2 | 38310234 | ||
| Pubmed | 3.99e-04 | 31 | 33 | 2 | 14630798 | ||
| Pubmed | 4.09e-04 | 1049 | 33 | 6 | 27880917 | ||
| Pubmed | 5.78e-04 | 407 | 33 | 4 | 12693553 | ||
| Interaction | RLN1 interactions | 2.90e-07 | 93 | 31 | 5 | int:RLN1 | |
| Interaction | CST9L interactions | 6.03e-06 | 78 | 31 | 4 | int:CST9L | |
| Interaction | FEZF1 interactions | 1.05e-05 | 28 | 31 | 3 | int:FEZF1 | |
| Interaction | PDLIM1 interactions | 1.38e-05 | 96 | 31 | 4 | int:PDLIM1 | |
| Interaction | RALY interactions | 1.48e-05 | 356 | 31 | 6 | int:RALY | |
| Interaction | FBXO2 interactions | 3.32e-05 | 411 | 31 | 6 | int:FBXO2 | |
| Interaction | EFHD2 interactions | 4.15e-05 | 127 | 31 | 4 | int:EFHD2 | |
| Interaction | TPM4 interactions | 4.36e-05 | 259 | 31 | 5 | int:TPM4 | |
| Interaction | TPM1 interactions | 4.69e-05 | 263 | 31 | 5 | int:TPM1 | |
| Interaction | HSPA1L interactions | 7.33e-05 | 289 | 31 | 5 | int:HSPA1L | |
| Interaction | TRGV3 interactions | 8.19e-05 | 55 | 31 | 3 | int:TRGV3 | |
| Interaction | MAPK11 interactions | 8.64e-05 | 56 | 31 | 3 | int:MAPK11 | |
| Interaction | AHNAK interactions | 1.15e-04 | 318 | 31 | 5 | int:AHNAK | |
| Interaction | IGKV2D-28 interactions | 1.50e-04 | 12 | 31 | 2 | int:IGKV2D-28 | |
| Interaction | PTPRK interactions | 1.50e-04 | 177 | 31 | 4 | int:PTPRK | |
| Interaction | ACTN1 interactions | 1.59e-04 | 341 | 31 | 5 | int:ACTN1 | |
| Interaction | ARPC2 interactions | 1.86e-04 | 187 | 31 | 4 | int:ARPC2 | |
| Interaction | YWHAH interactions | 1.99e-04 | 1102 | 31 | 8 | int:YWHAH | |
| Interaction | RNASE4 interactions | 2.06e-04 | 14 | 31 | 2 | int:RNASE4 | |
| Interaction | RAVER1 interactions | 2.14e-04 | 194 | 31 | 4 | int:RAVER1 | |
| Interaction | ZBTB17 interactions | 2.23e-04 | 77 | 31 | 3 | int:ZBTB17 | |
| Cytoband | 3p21 | 2.61e-04 | 33 | 33 | 2 | 3p21 | |
| Cytoband | 6p21.1 | 1.53e-03 | 80 | 33 | 2 | 6p21.1 | |
| GeneFamily | Actinins | 9.27e-06 | 4 | 23 | 2 | 1112 | |
| GeneFamily | Cullins | 4.31e-05 | 8 | 23 | 2 | 1032 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.32e-02 | 394 | 23 | 3 | 471 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-07 | 176 | 33 | 5 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-07 | 178 | 33 | 5 | 6f61490d79cd1727ed2d5cc673823dd4efdafac1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.04e-07 | 179 | 33 | 5 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-07 | 181 | 33 | 5 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.54e-07 | 200 | 33 | 5 | 7668ae7ed550583ab59e419c5c9bb9f2d7e8e0d5 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)----L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.54e-07 | 200 | 33 | 5 | 44f0278cb0e4ffcda4af3719d7f5819a10929b9f | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)---|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.54e-07 | 200 | 33 | 5 | 23da7790e09575b2ca909ed16806b44223bf1017 | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.54e-07 | 200 | 33 | 5 | 91f3df1c5a661ff703835f58a35cee93f18eb15c | |
| ToppCell | Neuronal-Excitatory-eF(C1QL3)--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.54e-07 | 200 | 33 | 5 | 2e2b1d252972b702ade25526ec8461bf613d81b0 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-06 | 163 | 33 | 4 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.92e-06 | 173 | 33 | 4 | 95c723b09254ae7131fe5ba0841472502e83269b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-06 | 176 | 33 | 4 | 057d2759fdc67176c25802b57a78064d8cc93205 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-06 | 176 | 33 | 4 | b81e5d23b31cefc8d374ef403e21acc390c14a80 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.67e-06 | 177 | 33 | 4 | 921783ed0fe20294d2f384d9136924b679df01bb | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.67e-06 | 177 | 33 | 4 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.06e-06 | 179 | 33 | 4 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.06e-06 | 179 | 33 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | (2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 9.46e-06 | 181 | 33 | 4 | ad14c7111d4fb924afd233cb114447f195373a7c | |
| ToppCell | COVID-19-kidney-Stressed_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.46e-06 | 181 | 33 | 4 | 6980ea624151da32b7f537f263e40fcb87a02e81 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-06 | 182 | 33 | 4 | d41ff834b8fc1d0e23cac7ae261de5f72874e462 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.67e-06 | 182 | 33 | 4 | 6cde859edfe7607bd7ada89d20258413d06f4207 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.67e-06 | 182 | 33 | 4 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 184 | 33 | 4 | 371c1927ac06b77ff462a94cca6acb802f9724ff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 184 | 33 | 4 | fbac70333e4f028bfbdd9cc9401427caac9f0c47 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 184 | 33 | 4 | dd6777a0cb49cd79fc439920c3c930a1e4681bb0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Endothelial_Myeloid|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 185 | 33 | 4 | 6b832b3e080dfadd21253ac45022192f4d3cb37b | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-05 | 185 | 33 | 4 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 186 | 33 | 4 | e41f14aee8cfbf76b8d0d4695a6170e2cd92aec8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 186 | 33 | 4 | b3633cd4e360c5b45060c50b4f606d483e03a89a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 186 | 33 | 4 | 9dd31dc9af1704f35c74de726a6c27fa21e9a014 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-05 | 187 | 33 | 4 | 23a42c172d5cc36cb8793c0bc2ce357c6c8e5d39 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-05 | 187 | 33 | 4 | 5ce7cf02990465b6f793205e4be07e8337b3570a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.08e-05 | 187 | 33 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-05 | 187 | 33 | 4 | 17a37fc3a1d62fef3137e5ff26a84c0b8c80e124 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-05 | 187 | 33 | 4 | 1b0eb29394040555516677b9de75c15e769c4c53 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-05 | 187 | 33 | 4 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-05 | 187 | 33 | 4 | 11c773cf3dc1e725b7e4d8edd676c8a94a231d2a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | 26c0a94951236a5d17a169920b0a8a9d0dd7d0ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | af300574c4e95505f56bf716bcee1e4777944e8e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | 5df5a0890e17d19f55770525345a656253696887 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | c65fb9a3c910dd6166853f4f3a2f2c2411ccf03b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | e169e9bb85892e52880ee949d0f691d0ea0c8dc9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | 9e923b0d79495ee1a3a097741a877f25d439eda3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Micro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 188 | 33 | 4 | 14dbc985abc2012c9f53deb243d465e4175f419f | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.10e-05 | 188 | 33 | 4 | d7a9fb5b021e127b8d927658a55a71098d513b5c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 189 | 33 | 4 | 389ccb68acb82893709f256315111470cf4beed3 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 189 | 33 | 4 | 58465b9407fbce91cca8f199950d6e0054c38fbc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 189 | 33 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 189 | 33 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 189 | 33 | 4 | e9fe8d17f4b7cca9bbf3655047e27b2fec5060c1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid-Micro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 189 | 33 | 4 | 7ac78441a15a82218deaafd47accff2ea5c8de20 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Endothelial_Myeloid|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 190 | 33 | 4 | d4f954e0748898df69e1710df558564db703dd61 | |
| ToppCell | COVID-19_Severe-B_intermediate|World / disease group, cell group and cell class | 1.17e-05 | 191 | 33 | 4 | f226fd69a26124ba98e4544f550b89a08e6a3708 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.19e-05 | 192 | 33 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | COVID-19-lung-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-05 | 192 | 33 | 4 | cbe57cda44232b183821ac633b60a2668265e616 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.22e-05 | 193 | 33 | 4 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-05 | 193 | 33 | 4 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-05 | 193 | 33 | 4 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-05 | 194 | 33 | 4 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 195 | 33 | 4 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 195 | 33 | 4 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-05 | 195 | 33 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-05 | 196 | 33 | 4 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 1.29e-05 | 196 | 33 | 4 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.32e-05 | 197 | 33 | 4 | 89fe4885efc8db142c0dc0506840ae8aceba9ef9 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-05 | 197 | 33 | 4 | 6a3c647af41fea923311562575a0d656fbc13cbe | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 198 | 33 | 4 | 898ef4f02443780f9b1fc08b73a165fda0ca5cde | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-05 | 198 | 33 | 4 | 42be18aef4f656a86c61630b061826a858c496fd | |
| ToppCell | 367C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.35e-05 | 198 | 33 | 4 | ab3a178f392204e2d90eb5a3b5de7849986b1eaf | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 198 | 33 | 4 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-05 | 198 | 33 | 4 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | 54167894a16e975d0541cbe3e515bcfa183044f6 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | b818d46a39c8782188d82dc8931b8eec9d549dd1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 33 | 4 | 6ce7612ee2ae211eb0f73391e96089ad5431c537 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 33 | 4 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 33 | 4 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 33 | 4 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 33 | 4 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 33 | 4 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 33 | 4 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 33 | 4 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 200 | 33 | 4 | 48ce43a27e78b2883e588e1a63fa5352c2deeeb7 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.40e-05 | 200 | 33 | 4 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.05e-05 | 103 | 33 | 3 | e28236a064a7c86e99e7e2edb1eb777f6034a9b4 | |
| ToppCell | control-Myeloid-Monocyte-derived_DC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.96e-05 | 108 | 33 | 3 | e74e73d89d78c8d59dfdd2bd30db54b366a49d23 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.76e-05 | 112 | 33 | 3 | 9801227fe5a6f5ae1b6c5a9e7fa7f35c4c52efe1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-04 | 131 | 33 | 3 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-mDC|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.26e-04 | 132 | 33 | 3 | f8e2ba53063007d7507f1837ad669b0e4333cd23 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 1.44e-04 | 138 | 33 | 3 | b2ab273f3e62f169b3b9cb82342e6617af99f582 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-04 | 140 | 33 | 3 | 7b359bfbd404ab06d799048252f4985d85852048 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.50e-04 | 140 | 33 | 3 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-04 | 144 | 33 | 3 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 147 | 33 | 3 | 26bd9d89e2e7b841cc18030bb7cebb642b987183 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-04 | 148 | 33 | 3 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.77e-04 | 148 | 33 | 3 | cb9365663f9cba35d47b5dd9079f42e88b70d915 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 1.81e-04 | 149 | 33 | 3 | 078e1e5765e476ba85c23fb8f6892b6698cbcbdb | |
| ToppCell | severe_influenza-Treg|World / disease group, cell group and cell class (v2) | 1.81e-04 | 149 | 33 | 3 | 2a3a00cdf604c8f3f3863df0ddb06938549bf86d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Rxfp1_Prdm8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.88e-04 | 151 | 33 | 3 | 090b067873740c282865e2d02cf47d5cb3dd7607 | |
| Disease | semaphorin-6A measurement | 6.83e-06 | 4 | 32 | 2 | EFO_0020721 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.14e-05 | 5 | 32 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.18e-05 | 8 | 32 | 2 | DOID:0060308 (implicated_via_orthology) | |
| Disease | Papillary Renal Cell Carcinoma | 3.61e-04 | 128 | 32 | 3 | C1306837 | |
| Disease | Renal Cell Carcinoma | 3.61e-04 | 128 | 32 | 3 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 3.61e-04 | 128 | 32 | 3 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 3.61e-04 | 128 | 32 | 3 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 3.61e-04 | 128 | 32 | 3 | C1266044 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.51e-04 | 148 | 32 | 3 | C0279702 | |
| Disease | rectum cancer | 9.55e-04 | 42 | 32 | 2 | EFO_1000657 | |
| Disease | cup-to-disc ratio measurement | 1.16e-03 | 430 | 32 | 4 | EFO_0006939 | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 2.07e-03 | 62 | 32 | 2 | DOID:9074 (is_implicated_in) | |
| Disease | C-X-C motif chemokine 10 measurement | 6.24e-03 | 109 | 32 | 2 | EFO_0008056 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGSSMTYHFQEHYTL | 1006 | Q9BZ76 | |
| MTYVSCFYHAFAGAE | 246 | P35609 | |
| LYKYFFFHHSHGDTM | 426 | Q9Y646 | |
| MAEHDYHEDYGFSSF | 1 | O00574 | |
| THWEYYAMTSFHYTI | 256 | O00574 | |
| AIMTYVSSFYHAFSG | 256 | O43707 | |
| YFDSYAHFGIHEEML | 76 | Q9NR22 | |
| FVEELFHGSYGTFYM | 281 | Q5VUD6 | |
| SYTFHGDPHAMFAEF | 91 | P25685 | |
| EFYFTYDGSHQRHVM | 31 | Q8N1W1 | |
| EHHTEMEFSFFYDTV | 3491 | Q86XX4 | |
| TDHSRMHWFSYYTTH | 3986 | Q9NZR2 | |
| YVDSHHEYPAMTFYS | 36 | Q92731 | |
| GYTTYDAHHSAFSQM | 191 | Q02556 | |
| FYHTTVISHSYCEHM | 171 | Q9UKL2 | |
| ATTFEHYYQHYMADR | 1261 | Q14999 | |
| FGFANSYIAMHYHTT | 506 | O95800 | |
| FYTMYFEEPDSSGHA | 316 | O14638 | |
| TTFEHFYQHYMADRL | 1591 | Q8IWT3 | |
| FTSGEHTNYYFDVSH | 141 | P14735 | |
| TGSSMTYHFQEHYTL | 1006 | Q96NU0 | |
| HHFYCYMIGHTLSTF | 511 | P22897 | |
| HFSVDTEGYYTSMHF | 776 | Q6T4R5 | |
| FELMHQNGDYTHFYF | 896 | O43147 | |
| AVYFCSGMDNDFHHY | 751 | Q9Y2L1 | |
| VFSMGEAVPYAHYEH | 511 | Q9NZQ3 | |
| TEFHNGHRYFYEMDE | 551 | Q9Y4E5 | |
| YYSSSFAQHMRIHTG | 321 | Q96NL3 | |
| MHHSSSYGVDYKRSY | 906 | Q9H2E6 | |
| TEGDMTVQCHYYTHY | 2621 | Q6ZS81 | |
| VFSYGSMFYSVHQSA | 596 | Q9HBX9 | |
| DHSDPMFSSYAYKSH | 876 | Q9BZ95 | |
| TTREYCEFMHGYFHE | 611 | Q6PJF5 | |
| SYKHTTSIFDDFSHY | 546 | Q9Y5A9 |